Literature DB >> 12065013

The pharmacotherapy of smoking cessation.

Matthew J Peters1, Lucy C Morgan.   

Abstract

1. The great majority of smokers are chronically dependent on tobacco. This dependence arises from the rituals and sensory associations of smoking that are reinforced, within seconds, by a rapid burst of nicotine from the cigarette. 2. All forms of nicotine replacement therapy (NRT) -- gum, patches and inhaler -- and bupropion are safe and effective for increasing smoking cessation rates in the short and long terms. 3. Other than those who are minimally dependent, all patients willing to quit should be offered one of these therapies unless contraindications exist. The effectiveness of drug treatments is multiplied when associated with effective counselling or behavioural treatments. 4. While NRT is not recommended during pregnancy or in patients with cardiac disease, if the alternative is smoking NRT is almost certainly safe. 5. Combination NRT (more than one therapy) may be indicated in patients who have failed monotherapy in association with withdrawal symptoms. 6. There are some specific contraindications to the use of bupropion. Its subsidised availability should not influence prescribers to ignore these.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065013     DOI: 10.5694/j.1326-5377.2002.tb04521.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

Review 1.  Combination treatment for nicotine dependence: state of the science.

Authors:  Karen S Ingersoll; Jessye Cohen
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

Review 2.  A review of smoking cessation interventions.

Authors:  Ashish Maseeh; Gagandeep Kwatra
Journal:  MedGenMed       Date:  2005-06-07

3.  Assessing preferences for improved smoking cessation medications: a discrete choice experiment.

Authors:  Joachim Marti
Journal:  Eur J Health Econ       Date:  2011-06-26

4.  Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes.

Authors:  A C Holloway; G E Lim; J J Petrik; W G Foster; K M Morrison; H C Gerstein
Journal:  Diabetologia       Date:  2005-11-04       Impact factor: 10.122

5.  Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.

Authors:  Margaret Rukstalis; Christopher Jepson; Andrew Strasser; Kevin G Lynch; Kenneth Perkins; Freda Patterson; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

6.  Hypericum perforatum attenuates nicotine withdrawal signs in mice.

Authors:  Maria A Catania; Fabio Firenzuoli; Anna Crupi; Carmen Mannucci; Achille P Caputi; Gioacchino Calapai
Journal:  Psychopharmacology (Berl)       Date:  2003-04-29       Impact factor: 4.530

Review 7.  Long-term consequences of fetal and neonatal nicotine exposure: a critical review.

Authors:  Jennifer E Bruin; Hertzel C Gerstein; Alison C Holloway
Journal:  Toxicol Sci       Date:  2010-04-02       Impact factor: 4.849

8.  Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.

Authors:  Margaret S Chisolm; Michelle Tuten; Emily C Brigham; Eric C Strain; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Sep-Oct

9.  Social factors, psychopathology, and maternal smoking during pregnancy.

Authors:  Stephen E Gilman; Joshua Breslau; S V Subramanian; Brian Hitsman; Karestan C Koenen
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.